13 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
the revenues we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain marketing approval
10-Q
40rj6 hh3
12 Nov 20
Quarterly report
8:01am
424B4
5pu348h
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
040ra
11 Sep 20
IPO registration
4:49pm
DRS/A
p0fbm194lu
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
ei0w0an6bf15rqzsj
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
kl5qmx r1
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
nau9zs7w
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next